AstraZeneca PLC Shares 2011-2026 | AZN

Annual Shares AstraZeneca PLC

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	1.42 B	2.6 B	2.6 B	2.53 B	2.53 B	2.53 B	2.53 B	2.52 B	2.5 B	2.52 B	2.72 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.72 B	1.42 B	2.46 B

Quarterly Shares AstraZeneca PLC

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	1.32 B	-	-	-	1.31 B	-	-	-	1.31 B	-	-	-	1.27 B	-	-	-	1.27 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.32 B	1.27 B	1.3 B

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
AbbVie ABBV	1.77 B	$ 208.84	-2.86 %	$ 369 B	USA
AbCellera Biologics ABCL	299 M	$ 3.52	0.28 %	$ 1.05 B	Canada
Grifols, S.A. GRFS	682 M	$ 8.24	-0.12 %	$ 6.83 B	Spain
Ascendis Pharma A/S ASND	54.8 M	$ 229.25	0.44 %	$ 5 B	Danmark
I-Mab IMAB	187 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
ANI Pharmaceuticals ANIP	19.3 M	$ 74.21	-2.3 %	$ 1.43 B	USA
Adverum Biotechnologies ADVM	19.8 M	-	-	$ 86.2 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Autolus Therapeutics plc AUTL	266 M	$ 1.41	2.17 %	$ 375 M	Britain
AgeX Therapeutics AGE	10.2 M	-	-10.17 %	$ 12.2 K	USA
Cocrystal Pharma COCP	11.3 M	$ 1.51	48.04 %	$ 17 M	USA
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
AIkido Pharma AIKI	14.3 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Allena Pharmaceuticals ALNA	68 M	-	3.16 %	$ 1.9 M	USA
BioMarin Pharmaceutical BMRN	192 M	$ 55.5	-3.04 %	$ 10.6 B	USA
Alpine Immune Sciences ALPN	33.4 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	25.4 M	-	10.36 %	$ 9.8 M	USA
Arcturus Therapeutics Holdings ARCT	27.4 M	$ 8.03	2.29 %	$ 220 M	Israel
Adaptive Biotechnologies Corporation ADPT	152 M	$ 14.81	2.63 %	$ 2.25 B	USA
Altimmune ALT	88.1 M	$ 3.34	7.05 %	$ 294 M	USA
BioNTech SE BNTX	244 M	$ 91.18	1.97 %	$ 27.2 B	Germany
Amgen AMGN	538 M	$ 347.94	-1.51 %	$ 187 B	USA
Aurinia Pharmaceuticals AUPH	134 M	$ 15.61	0.9 %	$ 2.1 B	Canada
Bristol-Myers Squibb Company BMY	2.03 B	$ 59.6	-2.45 %	$ 121 B	USA
Aptose Biosciences APTO	2.45 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	67.7 M	-	-39.0 %	$ 4.57 M	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
Burford Capital Limited BUR	219 M	$ 4.14	-2.59 %	$ 683 M	Britain
BioCryst Pharmaceuticals BCRX	207 M	$ 9.02	-3.84 %	$ 1.86 B	USA
Avenue Therapeutics ATXI	3.13 M	-	-52.27 %	$ 4.45 M	USA
Atea Pharmaceuticals AVIR	81.5 M	$ 5.76	1.95 %	$ 469 M	USA
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
AVROBIO AVRO	44.3 M	-	1083.1 %	$ 745 M	USA
Cellectis S.A. CLLS	44.8 M	$ 3.41	1.19 %	$ 116 M	France
Biogen BIIB	146 M	$ 177.34	-3.5 %	$ 26 B	USA
Axcella Health AXLA	54.4 M	-	-16.42 %	$ 249 M	USA
Axon Enterprise AXON	75.7 M	$ 412.81	-2.54 %	$ 31.3 B	USA